Teladoc Inc. ((TDOC)) has held its Q1 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Teladoc Inc. struck a cautious but constructive tone on its latest earnings call, pairing solid execution on strategic initiatives with acknowledgment of meaningful near‑term headwinds. Management highlighted upside from Integrated Care growth, expanding margins, and BetterHelp’s insurance ramp, while flagging pressure in the cash‑pay business, mix shifts, and capital structure overhangs that investors must watch closely.
Consolidated Revenue and EBITDA Beat
Teladoc opened the year ahead of plan, with Q1 consolidated revenue of $614 million and adjusted EBITDA of $58 million, both topping the midpoint of guidance. The 9.5% EBITDA margin underscored resilient profitability despite mix headwinds and seasonally weaker free cash flow, signaling disciplined execution across the portfolio.
Integrated Care Growth and Margin Expansion
Integrated Care remained Teladoc’s profit engine, delivering Q1 revenue of $395 million, up 1.5% year over year, with acquisitions adding roughly 170 basis points. Adjusted EBITDA climbed 12% to $56 million, pushing segment margin to 14.2% and showcasing tight cost control and leverage from scale even in a modest demand backdrop.
Membership and Chronic Care Traction
U.S. Integrated Care membership ended the quarter at 101.2 million, surpassing internal expectations and reinforcing Teladoc’s reach with large employers and health plans. Chronic Care enrollment reached 1.2 million members, growing about 1% sequentially and roughly 4% year over year, aided by increasing adoption of multi‑condition bundles.
BetterHelp Insurance Rollout Momentum
The BetterHelp insurance rollout is gaining traction, now live in 30 states plus Washington, D.C., with more than 6,000 providers credentialed. Covered lives exceed 150 million, up 30 million since year‑end, and insurance users log about 20% more sessions in their first 90 days, driving roughly 800 basis points better performance in mature insurance markets.
BetterHelp Insurance Revenue Acceleration
Insurance is quickly becoming a meaningful growth driver for BetterHelp, with Q1 insurance revenue hitting $13 million, up $6 million sequentially. Weekly insurance‑covered sessions now exceed 14,000, supporting an annualized revenue run rate above $75 million, and Teladoc lifted its full‑year insurance revenue outlook to a range of $90 million to $105 million.
Operational and AI-Driven Efficiency Gains
Teladoc emphasized AI and data investments as key levers for efficiency, highlighting tools like Pulse and Prism Care that streamline clinical workflows. AI‑assisted documentation has generated more than 300,000 notes for over 2,000 therapists, saving roughly 15 minutes per insurance session and totaling about 4 million minutes saved, while BetterHelp cut ad spend 12% year over year.
Financial Position and Cost Reduction Targets
The balance sheet remains a focal point, with $751 million of cash on hand and net debt to trailing adjusted EBITDA below 0.9 times, though gross leverage stands at 3.6 times. Management reiterated full‑year guidance and now expects stock‑based compensation under $55 million, implying a drop of more than 30% versus 2025 and over 70% since 2023.
BetterHelp Revenue and User Declines
Despite insurance momentum, BetterHelp’s core cash‑pay business is under pressure, with Q1 revenue of $218 million down 9% year over year. Average paying users also fell 9% to 361,000, as a mid‑teens decline in the U.S. more than offset high single‑digit growth in international markets, weighing on segment growth.
BetterHelp Margin Pressure and Near-term Losses
Profitability at BetterHelp deteriorated, with adjusted EBITDA of just $2 million and a slim 0.9% margin, down from 3.2% a year earlier. Lower‑margin insurance mix and investment to build that channel compressed margins, only partly offset by reduced advertising, pointing to a period of near‑term earnings drag before scale benefits emerge.
Free Cash Flow Outflow for the Quarter
Free cash flow was negative in the typically weak first quarter, with a $26 million net outflow reflecting seasonal patterns and working capital dynamics. Management framed this as a temporary dip, reiterating expectations for improved cash generation in the second half as profitability and collections strengthen.
Subscription-to-Visit Mix Shift Headwinds
Teladoc is navigating a customer shift from subscription‑based contracts to visit‑based pricing, which weighed on subscription revenue and gross margins in Q1. While the company expects the new mix to become a tailwind by 2026, the transition introduces short‑term revenue friction and requires careful management of utilization and pricing.
Implementation Timing Delays
Execution timing also added noise, as several client implementations originally slated for Q2 were pushed into the back half of 2026. Some business was pulled into Q1, creating a temporary benefit that will make quarter‑to‑quarter comparisons more volatile and complicate near‑term trend analysis for investors.
Therapist Capacity and Operational Constraints
Scaling the BetterHelp insurance business exposes a key bottleneck: therapist capacity and willingness to work under insurance workflows. Not all of BetterHelp’s roughly 30,000 therapists are opting in, meaning that despite more than 6,000 being credentialed, provider availability remains a gating factor for fully capturing insurance demand.
Gross Debt and Convertible Note Uncertainty
While net leverage is low, Teladoc still carries gross debt equal to about 3.6 times trailing EBITDA, including convertible notes that mature in 2027. Management laid out a two‑phase plan to materially reduce gross debt over time, but investors will be watching closely as execution and market conditions will determine how cleanly the capital structure can be de‑risked.
Guidance and Forward-Looking Outlook
Management reaffirmed 2026 consolidated guidance, targeting $2.48 billion to $2.58 billion in revenue, $267 million to $306 million of adjusted EBITDA, and $130 million to $170 million in free cash flow. Integrated Care is expected to grow modestly with margin expansion, while BetterHelp faces a small revenue decline in 2026 but rising insurance revenue and a return to low‑single‑digit EBITDA margins.
Teladoc’s earnings call painted a picture of a company in transition, balancing solid Integrated Care performance and promising insurance progress at BetterHelp against structural and cyclical pressures. For investors, the story now hinges on execution: successfully scaling insurance, managing the pricing mix shift, and addressing debt will determine whether current headwinds give way to the profitable growth outlined in management’s long‑term targets.

